Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL27738548 | 0.82 | TDP1 (0.35) | TDP1TSHR | |
| Methacrylic Acid SCHEMBL9365250 | 0.82 | TP53 (0.36) | TDP1TSHR | |
| Acetone SCHEMBL28230335 | 0.81 | LMNA (0.40) | TDP1TSHRLMNA | |
| Methacrylic Acid SCHEMBL9788914 | 0.81 | TDP1 (0.42) | TDP1TSHRLMNA | |
| Methacrylic Acid SCHEMBL17453353 | 0.80 | SLC7A5 (0.40) | TDP1TSHR | |
| Methacrylic Acid SCHEMBL203065 | 0.79 | TGFBR1 (0.31) | — | |
| Methacrylic Acid SCHEMBL28909098 | 0.79 | SLC7A5 (0.43) | TDP1TSHRLMNA | |
| Methacrylic Acid SCHEMBL9681885 | 0.78 | TDP1 (0.40) | TDP1TSHR | |
| Methacrylic Acid SCHEMBL28342863 | 0.78 | SLC7A5 (0.39) | TDP1TSHR | |
| Methacrylic Acid SCHEMBL5843019 | 0.78 | TDP1 (0.44) | TDP1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12178938-B2 | UV absorbing ocular lens | SEED CO., LTD. (JP) | 2024-12-31 | — | — | US | disclosed |
| EP-3894909-B1 | UV ABSORBING OCULAR LENS | SEED CO LTD (JP) | 2024-07-31 | — | — | EP | disclosed |
| CN-113316727-B | UV absorbing ophthalmic lenses | 株式会社实瞳 | 2024-07-09 | — | — | CN | disclosed |
| EP-3894909-A1 | UV ABSORBING OCULAR LENS | Seed Co., Ltd. (JP) | 2021-10-20 | — | — | EP | disclosed |
| WO-2020118361-A1 | UV ABSORBING OCULAR LENS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2020-06-18 | — | — | WO | disclosed |
| EP-2439579-B1 | WETTABLE HYDROGEL CONTACT LENS AND METHOD FOR PRODUCING SAME | SEED CO LTD (JP) | 2018-11-07 | — | — | EP | disclosed |
| US-9329408-B2 | Wettable hydrogel contact lens and method for producing same | SEED CO., LTD. (JP) | 2016-05-03 | — | — | US | disclosed |
| US-20120074352-A1 | WETTABLE HYDROGEL CONTACT LENS AND METHOD FOR PRODUCING SAME | SEED CO., LTD. (JP) | 2012-03-29 | — | — | US | disclosed |
| EP-1234681-B1 | Reversible thermosensitive recording medium and image processing method using the same | RICOH KK (JP) | 2007-04-18 | — | — | EP | disclosed |
| US-6770592-B2 | Reversible thermosensitive recording medium and image processing method using the same | RICOH COMPANY, LTD. (JP) | 2004-08-03 | — | — | US | disclosed |
| US-20030092571-A1 | Reversible thermosensitive recording medium and image processing method using the same | RIOCH COMPANY, LTD. (JP) | 2003-05-15 | — | — | US | disclosed |
| EP-1234681-A1 | Reversible thermosensitive recording medium and image processing method using the same | Ricoh Company, Ltd. (JP) | 2002-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12178938-B2 | UV absorbing ocular lens | UACA, PHYKPL, UROD | TDP1 1734/4885TSHR 3486/4885LMNA 243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.